NeuroOne receives Nasdaq deficiency notice for bid price below $1.00

NEUROONE MEDICAL TECHNOLOGIES Corp

Closing bid price was below $1.00 for 30 consecutive business days; 180-day cure period ends Nov. 3, 2025.
To regain compliance, stock must close at or above $1.00 for at least 10 consecutive business days.
If not cured by Nov. 3, may qualify for a second 180-day period if other initial listing standards are met.
Company says it will monitor and consider options but gives no assurance of regaining compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.